We are excited to announce the release of our next educational presentation. This lecture on comparing antipsychotics and the risk of weight gain promises to be an informative and relevant event for mental health professionals.
Understanding the impact of antipsychotic medications on weight gain is essential in providing comprehensive care for patients with mental health conditions. By staying up-to-date with the latest evidence and considerations for clinical practice, we can make informed decisions when prescribing antipsychotic medications, and minimize the risk of weight gain and its associated health consequences.
We look forward to a thought-provoking educational presentation, and we hope to see you there!
Time's up
Answer: Aripiprazole
Aripiprazole had ascending curve for weight gain, with curves still ascending at higher doses.
Risperidone: had plateau curve at higher dose.
Quetiapine XR, Lurasidone & Cariprazine: had quasi-parabolic curve with less weight gain at higher doses.
LECTURE SCHEDULE
(1) UPDATE 2023: Antipsychotics & Weight Gain
Antipsychotics with the LOWEST and HIGHEST risk of weight gain.
Which antipsychotic(s) weight-gain risk is LOWER AT HIGH DOSES?
Which antipsychotic(s) weight-gain risk PLATEAUS AT HIGH DOSES?
Which antipsychotic(s) weight-gain risk is HIGHER AT HIGH DOSES?
Quetiapine XR versus IR formulation: for weight gain and metabolic parameters.
Do LONG-ACTING INJECTABLES differ in the risk of weight gain?
Please note:
This action will also remove this member from your connections and send a report to the site admin.
Please allow a few minutes for this process to complete.